Student Author Information

Sarah HammockFollow

Access Type

Campus Access Only

Presentation Type

Oral Presentation

Start Date

April 2019

Department

Nursing

Abstract

Opioid medication is commonly prescribed to those with chronic illness that experience long-term pain. This type of medication is necessary, but also produces severe adverse effects if suddenly discontinued. In women with chronic illness that need opioid medication for chronic non-cancer pain, caution is used to prevent pregnancy because of the negative effects opioids have on the fetus. Opioids can cause miscarriage, premature birth, various birth defects, and neonatal abstinence syndrome; however, they are still being prescribed for women who may become or are already pregnant. This literature review was conducted to investigate the current policies related to maternal opioid use in chronic illness. Prescription opioid policies for chronic illness pain and during pregnancy are thoroughly discussed, and connections are made between the two populations to form recommendations for maternal opioid use in chronic illness. The themes of the literature review include, the importance of attempting more conservative treatment options before introducing opioids, the provider’s responsibility to review family planning and effects of long-term opioid use, and the necessity of routine monitoring of mother and fetus. Opioid prescriptions are necessary for women that experience pain associated with chronic illness, but recommendations specific to this population should be addressed to avoid unnecessary complications.

Faculty Mentor(s)

Dr. Laura Kicklighter, Professor Susan Braud, and Dr. Sara Hallowell

Rights Statement

The right to download or print any portion of this material is granted by the copyright owner only for personal or educational use. The author/creator retains all proprietary rights, including copyright ownership. Any editing, other reproduction or other use of this material by any means requires the express written permission of the copyright owner. Except as provided above, or for any other use that is allowed by fair use (Title 17, §107 U.S.C.), you may not reproduce, republish, post, transmit or distribute any material from this web site in any physical or digital form without the permission of the copyright owner of the material.

Share

COinS
 
Apr 10th, 1:30 PM

The Safety of Maternal Opioid Use in Chronic Illness Related to Newborn Withdrawal

Opioid medication is commonly prescribed to those with chronic illness that experience long-term pain. This type of medication is necessary, but also produces severe adverse effects if suddenly discontinued. In women with chronic illness that need opioid medication for chronic non-cancer pain, caution is used to prevent pregnancy because of the negative effects opioids have on the fetus. Opioids can cause miscarriage, premature birth, various birth defects, and neonatal abstinence syndrome; however, they are still being prescribed for women who may become or are already pregnant. This literature review was conducted to investigate the current policies related to maternal opioid use in chronic illness. Prescription opioid policies for chronic illness pain and during pregnancy are thoroughly discussed, and connections are made between the two populations to form recommendations for maternal opioid use in chronic illness. The themes of the literature review include, the importance of attempting more conservative treatment options before introducing opioids, the provider’s responsibility to review family planning and effects of long-term opioid use, and the necessity of routine monitoring of mother and fetus. Opioid prescriptions are necessary for women that experience pain associated with chronic illness, but recommendations specific to this population should be addressed to avoid unnecessary complications.